EKF Diagnostics Holdings plc (EKDHF)
OTCMKTS
· Delayed Price · Currency is USD
0.2474
0.00 (0.00%)
At close: Apr 22, 2025
EKF Diagnostics Holdings Revenue
In the year 2024, EKF Diagnostics Holdings had annual revenue of 50.19M GBP, down -4.59%. EKF Diagnostics Holdings had revenue of 24.98M in the half year ending December 31, 2024, a decrease of -14.34%.
Revenue
50.19M GBP
Revenue Growth
-4.59%
P/S Ratio
1.97
Revenue / Employee
158.34K GBP
Employees
317
Market Cap
123.93M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 50.19M | -2.42M | -4.59% |
Dec 31, 2023 | 52.61M | -14.02M | -21.05% |
Dec 31, 2022 | 66.64M | -15.20M | -18.57% |
Dec 31, 2021 | 81.84M | 16.58M | 25.40% |
Dec 31, 2020 | 65.26M | 20.34M | 45.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |